Preparing Your Clinic for the 2026 Severe Hay Fever Season: Demand Drivers & Patient Management Solutions

As spring begins across Australia, environmental health reporting indicates that the upcoming pollen season could hit earlier and with greater intensity than usual. Meteorologists and aerobiologists cite conditions associated with a Super El Niño (specifically hot, dry, and high-wind forecasts) as primary drivers for accelerated pollen release and heightened thunderstorm asthma risks.

For allergy and immunology practices, this annual influx presents both an operational capacity challenge and a vital patient care opportunity.

Shifting Patient Preference Toward Immunotherapy While symptom management via daily over-the-counter antihistamines remains standard practice, rising cumulative retail costs are prompting more patients to seek long-term, disease-modifying interventions.

Recent clinical commentary highlights several key points practitioners should prepare to address during initial consultations:

• Modality Selection: Patients are increasingly seeking clarity on subcutaneous immunotherapy (SCIT) via monthly injections (typically over a 3 to 5 year protocol) versus sublingual immunotherapy (SLIT) daily drops.
• Clinical Efficacy Data: Communicating realistic expectations is critical, with clinical trials and field data demonstrating significant symptom reduction in over 50% to 60% of compliant patients.
• Financial Consultation: Because allergen desensitisation treatments remain unlisted on Medicare, setting clear expectations around out-of-pocket costs early in the intake process reduces treatment drop-off.

Operational Readiness Checklist for Practices

1. Capacity & Flow: Audit nurse scheduling to accommodate increased injection appointments and mandatory post-injection observation windows during peak spring months.
2. Patient Education: Equip front-desk and intake staff with clear collateral comparing daily symptomatic relief with desensitisation pathways.
3. Emergency Protocols: Review clinic protocols for acute asthma exacerbations and anaphylaxis handling ahead of high-pollen and thunderstorm weather events.

Source Reference: Market trends and environmental updates adapted from clinical coverage by 7NEWS .